Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Dancing”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 739 records · Page 41Linked to original sources

Sharing with the land of the dancing lights.

In this article, the authors discuss some of their experiences with an innovative project that involved a group of faculty engaged in a collegial model of mentorship through the use of distance technology. In 2001, Aurora College in Yellowknife, Northwest Territories, entered into contract with the Collaborative Nursing Program (CNP) in British Columbia to develop a four-year BSN program. The contract included a curriculum development and faculty mentoring package for each year of the new program. In preparation for implementing the first year of the new curriculum, a mentoring partnership was set up involving the Aurora faculty who would be teaching the first three faculty members from the CNP sites at North Island College in Courtenay, University College of the Cariboo in Kamloops and Selkirk College in Castlegar. Aside from the initial two-day face-to-face workshop in Yellowknife and the occasional meeting of individuals at nursing conferences, mentoring took place across the miles, via teleconferencing and e-mail. At the end of the one-year project, all participants felt energized and enriched by the experience.

British Columbia↗

Everybody's doing a brand new dance now...CT/CTA coronary.

Before you purchase new equipment to perform this service make sure you have all the facts regarding reimbursement for your payor population to ensure correct financial calculations. There is not much argument that CTA of the coronary arteries holds the future and will replace many traditional diagnostic cardiac catheterization procedures. It is important to remember that this is another instance where technology is once again ahead of reimbursement.

Coronary Angiography↗

The future in advanced prostate cancer: take your partners or is the last dance for me?

Recent therapeutic initiatives have improved quality of life and survival for patients with advanced prostate cancer. This review focuses predominantly on prostate cancer that has become refractory to standard androgen ablation treatment. Planned trials will answer further questions on the optimal use and sequencing of currently available hormonal agents, cytotoxic therapies, and radiolabeled nucleotides. Future therapeutic advances are likely to come in 2 areas: targeted therapies and response prediction. Molecular targeted agents will be most useful in combination with each other or with established systemic therapies. The selection of combinations will require the application of paradigms targeting key biochemical pathways and specific microenvironments in prostate cancer. Response prediction for individual patients may be assisted by either pretreatment or sequential molecular profiling, or sequential imaging, or biochemical studies that predicate outcome prior to or soon after treatment has been initiated. To bring these advances to the metastatic prostate cancer patient, a series of well-designed clinical trials is needed that integrates the lessons learned through laboratory, translational, and clinical studies in recent years.

Journal Article↗